Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

Experimental orthotopic implantation of tissue-engineered tracheal graft created based on devitalized scaffold seeded with mesenchymal and epithelial cells

https://doi.org/10.15825/1995-1191-2019-4-96-107

Abstract

Objective: to study the viability of a tissue-engineered graft (TEG) based on a devitalized tracheal scaffold (DTS) seeded with mesenchymal stromal and epithelial cells in an experiment on rabbits with assessment of cytocompatibility and biocompatibility in vivo. Materials and methods. Syngeneic mesenchymal stromal bone marrow cells (MSBMCs) and syngeneic lung epithelial cells of rabbit were obtained. The morphology and phenotype of the MSBMC culture were confirmed via immunofluorescence staining for CD90 and CD271 markers. Pulmonary epithelial cells obtained by enzymatic treatment of minced rabbit lung tissue were stained with CKPan, CK8/18 and CK14 markers characteristic of epithelial cells. The donor trachea was devitalized in three successive freezethawing cycles. Double-layer cell seeding of DTS was performed under static and dynamic culturing. Orthotopic implantation of TEGs was performed at the site of the anterolateral wall defect in the rabbit that was formed as a result of tracheal resection over four rings. Results were evaluated by computed tomography, histological and immunohistochemical analyzes. Results. A TEG implant, based on DTS, with bilayer colonization by cell cultures of rabbit MSBMC and epithelial cells was obtained. Three months after implantation, TEG engraftment was noted, no tracheal wall stenosis was observed. However, slight narrowing of the lumen in the implantation site was noted. Six months after implantation, viability of TEG was confirmed by histological method. Epithelialization and vascularization of the tracheal wall, absence of signs of purulent inflammation and aseptic necrosis were shown. The small narrowing of the lumen of trachea was found to have been caused by chronic inflammation due to irritation of the mucous membrane with suture material. Conclusion. A new model for assessing the viability of a tissue engineering implant when closing a critical airway defect was created. The developed TEG – based on DTS seeded (bilayer) by lung epithelial cells and BMSCs – was successfully used to replace non-extended tracheal defects in an in vivo experiment. The use of tracheal tissue-engineered graft for orthotopic implantation showed biocompatibility with minimal tissue response.

About the Authors

M. V. Balyasin
Sechenov First Moscow State Medical University
Russian Federation

Balyasin Maksim Vitalievich

8/1, Trubetskaya str., Moscow, 119991.
Тел. (999) 772-58-69



D. S. Baranovsky
University Hospital of Basel
Switzerland
Basel


A. G. Demchenko
Sechenov First Moscow State Medical University
Russian Federation
Moscow


A. L. Fayzullin
Sechenov First Moscow State Medical University
Russian Federation
Moscow


O. A. Krasilnikova
Sechenov First Moscow State Medical University
Russian Federation
Moscow


I. D. Klabukov
Sechenov First Moscow State Medical University
Russian Federation
Moscow


M. E. Krasheninnikov
Sechenov First Moscow State Medical University
Russian Federation
Moscow


A. V. Lyundup
Sechenov First Moscow State Medical University
Russian Federation
Moscow


V. D. Parshin
Sechenov First Moscow State Medical University
Russian Federation
Moscow


References

1. Barbetakis N, Samanidis G, Paliouras D, Lafaras C, Bischiniotis T, Tsilikas C. Intraoperative tracheal reconstruction with bovine pericardial patch following iatrogenic rupture. Patient Saf Surg. 2008; 2 (1): 4. doi: 10.1186/1754-9493-2-4.

2. Golub IE, Pinsky SB, Netesin ES. Postintubational damage of trachea. The Siberian Medical Journal. 2009; 87 (4): 124–128. [In Russ].

3. Sokolovich AG, Dering EV, Horoshilov IA. Inefficiency and prophylaxis of anastomosis after circular resection of trachea. Siberian Medical Review. 2006; 40 (3): 17–20. [In Russ, English abstract].

4. Parshin VD, Lyundup AV, Tarabrin EA, Parshin VV. Long-term oucomes of tracheal transplantation: success and unsolved problems. Khirurgiia. J. im. N.I. Pirogova. 2018; (11): 11–19. [In Russ, English abstract]. doi: 10.17116/hirurgia201811111.

5. Law JX, Liau LL, Aminuddin BS, Ruszymah BH. Tissueengineered trachea: a review. Int J Pediatr Otorhinolaryngol. 2016; 91: 55–63. doi: 10.1016/j.ijporl.2016.10.012.

6. Baranovsky DS, Demchenko AG, Oganesyan RV, Lebedev GV, Berseneva DA, Balyasin MV et al. Acellular tracheal cartilaginous scaffold producing for tissue-engineered constructs. Vestn Ross Akad Med Nauk. 2017; 72 (4): 254–260. [In Russ, English abstract]. doi: 10.15690/vramn723.

7. Kuevda EV, Gubareva EA, Sotnichenko AS, Gumenyuk IS, Gilevich IV, Polyakov IS et al. Experience of perfusion recellularization of biological lung scaffold in rats. Russian Journal of Transplantology and Artificial Organs. 2016; 18 (1): 38–44. [In Russ, English abstract]. doi: 10.15825/1995-1191-2016-1-38-44.

8. Seguin A, Baccari S, Holder-Espinasse M, Bruneval P, Carpentier A, Taylor DA et al. Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. J Thorac Cardiovasc Surg. 2013; 145 (5): 1297–1304. doi: 10.1016/j.jtcvs.2012.09.079.

9. Go T, Jungebluth P, Baiguero S, Asnaghi A, Martorell J, Ostertag H et al. Both epithelial cells and mesenchymal stem cell–derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg. 2010; 139 (2): 437–443. doi: 10.1016/j.jtcvs.2009.10.002.

10. Jungebluth P, Bader A, Baiguera S, Möller S, Jaus M, Lim ML et al. The concept of in vivo airway tissue engineering. Biomaterials. 2012; 33 (17): 4319–4326. doi: 10.1016/j.biomaterials.2012.03.016.

11. Shin YS, Choi JW, Park JK, Kim YS, Yang SS, Min BH et al. Tissue-engineered tracheal reconstruction using mesenchymal stem cells seeded on a porcine cartilage powder scaffold. Ann Biomed Eng. 2015; 43 (4): 10031013. doi: 10.1007/s10439-014-1126-1.

12. Nakayama GR, Caton MC, Nova MP, Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods. 1997; 204 (2): 205–208. doi: 10.1016/S0022-1759(97)00043-4.

13. Jetten AM, George MA, Smits HL, Vollberg TM. Keratin 13 expression is linked to squamous differentiation in rabbit tracheal epithelial cells and down-regulated by retinoic acid. Exp Cell Res. 1989; 182 (2): 622–634. doi: 10.1016/0014-4827(89)90264-4.

14. Roth SP, Glauche SM, Plenge A, Erbe I, Heller S, Burk J. Automated freeze-thaw cycles for decellularization of tendon tissue-a pilot study. BMC biotechnology. 2017; 17 (1): 13. doi: 10.1186/s12896-017-0329-6.

15. Chang CH, Chen CC, Liao CH, Lin FH, Hsu YM, Fang HW. Human acellular cartilage matrix powders as a biological scaffold for cartilage tissue engineering with synovium-derived mesenchymal stem cells. J Biomed Mater Res A. 2014; 102 (7): 2248–2257. doi: 10.1002/jbm.a.34897.

16. Lyundup AV, Demchenko AG, Tenchurin TH, Krasheninnikov ME, Klabukov ID, Shepelev AD et al. Improving the seeding effectiveness of stromal and epithelial cell cultures in biodegradable matrixes by dynamic cultivation. Genes and Cells. 2016; 11 (3): 102–107. [In Russ, English abstract].


Review

For citations:


Balyasin M.V., Baranovsky D.S., Demchenko A.G., Fayzullin A.L., Krasilnikova O.A., Klabukov I.D., Krasheninnikov M.E., Lyundup A.V., Parshin V.D. Experimental orthotopic implantation of tissue-engineered tracheal graft created based on devitalized scaffold seeded with mesenchymal and epithelial cells. Russian Journal of Transplantology and Artificial Organs. 2019;21(4):96-107. https://doi.org/10.15825/1995-1191-2019-4-96-107

Views: 142185


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)